"Obesity is a chronic disease, and people living with obesity deserve treatment options that match the complex biology of their neurometabolic disease," said Ania Jastreboff, M.D., Ph.D., Professor of Medicine & Pediatrics (Endocrinology) at the Yale School of Medicine, Director of the Yale Obesity Research Center (Y-Weight), and lead investigator
As children with SMA may have a limited carnitine synthetic capacity due to significantly diminished skeletal muscle mass, and VPA is known to inhibit carnitine transport and deplete carnitine levels by binding to VPA metabolites, we elected to combine VPA therapy with sufficient supplemental carnitine to avoid concerns about a confounding effect of carnitine depletion
Transitioning to N-acetylcysteine (NAC) or alpha-lipoic acid may be appropriate if you need ongoing antioxidant support but want to reduce cost or shift to a compound that supports endogenous synthesis rather than providing exogenous glutathione
While some people regain the weight (youve likely heard of it as Ozempic rebound though this can happen with any ), it can be because of a natural consequence of stopping the medicationan increase in your appetite and fewer feelings of fullness
Some people experience intense itching
Regulatory bodies globally continue to emphasize that, as of 2026, none of the specific formulations contained within the KLIKGLOW complex have achieved standard medical approval for human therapeutic use
